Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06807866 · ClinicalTrials.gov registry record · Phase 4
Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT
A Phase 4 study of THA, sponsored by University of Miami.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT06807866: Recruiting Phase 4 study of THA, sponsored by University of Miami.
NCT06807866 is a Phase 4 study of THA that is actively recruiting participants, run by University of Miami. The registered enrollment target is 64 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06807866, a Phase 4 study of THA, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to compare total narcotic intake standardized via milligram morphine equivalents between duloxetine and placebo cohorts after a total hip arthroplasty.
Primary Outcome
The primary outcome measure was milligram morphine equivalent units to measure pain intensity difference and total pain relief
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Duloxetine
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2026-12-01 |
| Phase | Phase 4 |
What NCT06807866 shows while recruiting
NCT06807866 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 1 condition, with THA appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06807866 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06807866 about?
NCT06807866 is a clinical study titled "Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT". The primary objective of this study is to compare total narcotic intake standardized via milligram morphine equivalents between duloxetine and placebo cohorts after a total hip arthroplasty.
What is the current status of trial NCT06807866?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2025-03-01. Estimated completion is 2026-12-01.
What conditions does trial NCT06807866 study?
This clinical trial studies the following conditions: THA.
What interventions are being tested in trial NCT06807866?
The interventions under investigation include: Placebo (OTHER), Duloxetine (DRUG).
Who is sponsoring clinical trial NCT06807866?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06807866 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for THA
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06807866's enrollment target sits among peer trials
64 1098th of 2000 higher than 896 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI